Winnergy Medical PCL
SET:WINMED
Balance Sheet
Balance Sheet Decomposition
Winnergy Medical PCL
Winnergy Medical PCL
Balance Sheet
Winnergy Medical PCL
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
15
|
18
|
7
|
8
|
126
|
72
|
35
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
72
|
35
|
0
|
|
| Cash Equivalents |
15
|
18
|
7
|
8
|
126
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
123
|
168
|
153
|
182
|
204
|
265
|
353
|
396
|
|
| Accounts Receivables |
123
|
168
|
153
|
182
|
204
|
262
|
337
|
361
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
4
|
16
|
36
|
|
| Inventory |
82
|
58
|
60
|
62
|
79
|
78
|
120
|
117
|
|
| Other Current Assets |
2
|
2
|
5
|
4
|
7
|
25
|
11
|
15
|
|
| Total Current Assets |
221
|
246
|
225
|
256
|
417
|
440
|
519
|
551
|
|
| PP&E Net |
102
|
93
|
82
|
165
|
260
|
284
|
349
|
432
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
284
|
349
|
432
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
94
|
136
|
167
|
|
| Intangible Assets |
0
|
0
|
12
|
13
|
13
|
18
|
24
|
38
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
51
|
32
|
10
|
|
| Long-Term Investments |
0
|
2
|
0
|
46
|
52
|
38
|
38
|
63
|
|
| Other Long-Term Assets |
9
|
11
|
12
|
12
|
14
|
17
|
15
|
11
|
|
| Total Assets |
332
N/A
|
352
+6%
|
332
-6%
|
492
+48%
|
755
+54%
|
848
+12%
|
978
+15%
|
1 106
+13%
|
|
| Liabilities | |||||||||
| Accounts Payable |
53
|
48
|
69
|
59
|
95
|
24
|
69
|
90
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
20
|
18
|
22
|
|
| Short-Term Debt |
247
|
244
|
105
|
156
|
23
|
90
|
154
|
111
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
8
|
3
|
17
|
17
|
39
|
|
| Other Current Liabilities |
34
|
49
|
50
|
14
|
8
|
22
|
19
|
40
|
|
| Total Current Liabilities |
334
|
341
|
224
|
237
|
129
|
174
|
276
|
302
|
|
| Long-Term Debt |
0
|
0
|
0
|
51
|
38
|
64
|
86
|
158
|
|
| Minority Interest |
21
|
66
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
12
|
14
|
17
|
16
|
17
|
16
|
12
|
14
|
|
| Total Liabilities |
325
N/A
|
289
-11%
|
241
-17%
|
303
+26%
|
183
-40%
|
253
+38%
|
374
+48%
|
474
+27%
|
|
| Equity | |||||||||
| Common Stock |
5
|
55
|
55
|
140
|
200
|
200
|
200
|
200
|
|
| Retained Earnings |
2
|
8
|
36
|
49
|
72
|
107
|
116
|
132
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
300
|
300
|
300
|
300
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
12
|
12
|
0
|
|
| Total Equity |
7
N/A
|
63
+829%
|
91
+44%
|
189
+108%
|
572
+203%
|
595
+4%
|
604
+2%
|
632
+5%
|
|
| Total Liabilities & Equity |
332
N/A
|
352
+6%
|
332
-6%
|
492
+48%
|
755
+54%
|
848
+12%
|
978
+15%
|
1 106
+13%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
400
|
400
|
400
|
400
|
400
|
400
|
400
|
400
|
|